Inhibition of 5-lipoxygenase triggers apoptosis in prostate cancer cells via down-regulation of protein kinase C-epsilon
- 1 December 2011
- journal article
- research article
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Molecular Cell Research
- Vol. 1813 (12) , 2108-2117
Abstract
No abstract availableKeywords
Funding Information
- United States Department of Defense Prostate Cancer Research Programs (DAMD 17-02-1-0153, W81XWH-05-1-0022)
- Henry Ford Health System (A-10203)
This publication has 53 references indexed in Scilit:
- Genetic Ablation of PKC Epsilon Inhibits Prostate Cancer Development and Metastasis in Transgenic Mouse Model of Prostate AdenocarcinomaCancer Research, 2011
- Eicosanoids and cancerNature Reviews Cancer, 2010
- Protein kinase Cε makes the life and death decisionCellular Signalling, 2007
- AKT/PKB Signaling: Navigating DownstreamCell, 2007
- Diazoxide acts more as a PKC‐ɛ activator, and indirectly activates the mitochondrial KATP channel conferring cardioprotection against hypoxic injuryBritish Journal of Pharmacology, 2006
- What are cyclooxygenases and lipoxygenases doing in the driver's seat of carcinogenesis?International Journal of Cancer, 2006
- The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolismNature Reviews Genetics, 2006
- Exploiting the PI3K/AKT Pathway for Cancer Drug DiscoveryNature Reviews Drug Discovery, 2005
- Perturbations of the AKT signaling pathway in human cancerOncogene, 2005
- Protein kinase Cɛ interacts with Bax and promotes survival of human prostate cancer cellsOncogene, 2003